Salt producer Compass Minerals' Q4 net loss narrows on Plant Nutrition strength

Reuters
2025/12/09
Salt producer Compass Minerals' Q4 net loss narrows on Plant Nutrition strength

Overview

  • Compass Minerals Q4 revenue beats analyst expectations, reaching $227.5 mln

  • Net loss for Q4 reduced to $7.2 mln from $48.3 mln year-over-year

  • Adjusted EBITDA for Q4 rises to $41.6 mln, reflecting strategic changes

Outlook

  • Compass Minerals projects 2026 adjusted EBITDA between $200 mln and $240 mln

  • Salt segment 2026 adjusted EBITDA expected between $225 mln and $255 mln

  • Plant Nutrition segment 2026 adjusted EBITDA forecasted at $31 mln to $36 mln

Result Drivers

  • BACK-TO-BASICS STRATEGY - Co attributes improved performance to execution of back-to-basics strategy focusing on core Salt and Plant Nutrition businesses

  • INVENTORY OPTIMIZATION - Successful initiatives reduced North American highway deicing inventory value and volumes by 33% and 36%, respectively

  • PLANT NUTRITION PROFITABILITY - Improved profitability in Plant Nutrition segment due to increased sales volumes and cost structure reduction

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Beat

$227.50 mln

$223.50 mln (2 Analysts)

Q4 Adjusted Net Income

-$7.20 mln

Q4 Net Income

-$7.20 mln

Q4 Adjusted EBITDA

$41.60 mln

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the diversified chemicals peer group is "buy."

  • Wall Street's median 12-month price target for Compass Minerals International Inc is $20.00, about 1.4% below its December 5 closing price of $20.28

  • The stock recently traded at 24 times the next 12-month earnings vs. a P/E of 26 three months ago

Press Release: ID:nBw15j6pva

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10